Despite a lacklustre FDI environment in British life sciences, the pharma industry could be set for a period of renaissance ...

The recent UK–US policy developments are reshaping global pharmaceutical investment and launch strategies, as governments on ...

LONDON, July 2 (Reuters) - The British government and the pharmaceutical industry remain far apart in a dispute over drug pricing that has delayed publication of a long-pending plan for the UK life ...

The U.K. government is proposing to raise the rebate rate under a national drug cost program, drawing complaints from the Association of the British Pharmaceutical Industry (ABPI). As one of the two ...

Again, my previous article included more industry overview, but I thought I would add a little more here. I am writing this article comparing my tier two companies for a couple of reasons. First, this ...

Dublin, Dec. 22, 2025 (GLOBE NEWSWIRE) -- The "An Essential Overview of the Pharmaceutical and Biotech Industries Training Course (Mar 12, 2026)" training has been added to ResearchAndMarkets.com's ...

Andreas Eschbach is the founder and CEO of eschbach, a software company that helps production teams work smarter and enhance collaboration. The pharmaceutical industry stands at a critical juncture.